Table 2.
Expression levels of ptk6, ALT-PTK6, and ptk6/ALT-PTK6 ratio in relation to hormone receptor status of breast cancer.
| HR Status | Transcript Level (Mean ± SD) | p Value a | ||
|---|---|---|---|---|
| ALT-PTK6 | ER | ER (−) | 320.5 ± 107.0 | 0.15 |
| ER (+) | 181.9 ± 68.9 | |||
| PTK6 | ER (−) | 4.6 ± 2.4 | 0.262 | |
| ER (+) | 3.0 ± 1.6 | |||
| PTK6/ALT-PTK6 ratio | ER (−) | 10,842.3 ± 5207.3 | 0.042 | |
| ER (+) | 4.5 ± 4.5 | |||
| ALT-PTK6 | HER2 | HER2 (−) | 274.1 ± 139.8 | 0.976 |
| HER2 (+) | 266.4 ± 78.4 | |||
| PTK6 | HER2 (−) | 3.7 ± 1.8 | 0.796 | |
| HER2 (+) | 4.0 ± 1.9 | |||
| PTK6/ALT-PTK6 ratio | HER2 (−) | 10,885.8 ± 7001.6 | 0.616 | |
| HER2 (+) | 8937.8 ± 4141.9 | |||
| ALT-PTK6 | PR | PR (−) | 306.1 ± 90.6 | 0.2 |
| PR (+) | 168.1 ± 75.5 | |||
| PTK6 | PR (−) | 4.4 ± 2.0 | 0.314 | |
| PR (+) | 1.4 ± 0.4 | |||
| PTK6/ALT-PTK6 ratio | PR (−) | 9437.09 ± 4479.549 | 0.565 | |
| PR (+) | 6507.15 ± 4462.946 | |||
a ANOVA test.